SensDx is working on the technology of ultra-sensitive micorsensors, modified with biological molecules. The molecules on the electrode surface are selected by biotechnological methods. It allows you to identify unambiguously which bacteria or virus is the cause of infection or to determine the oncological marker, DNA or RNA.
Currently, works in the field of cardiology, oncology, urology and veterinary medicine are being carried out.
Multi SensDx - test for identification of upper respiratory tract infections causes
Multisensor is a rapid diagnostic test to identify the etiology of an upper respiratory tract infection that identifies more than one pathogen in a single sample. Proper diagnosis of the causes of the infection will allow for effective and precise therapy, which will reduce the unnecessary use of antibiotics in cases where the infection is viral.
We are awarded and honored in the Innovative Company category during the Final of the 13th edition of the Innovator Mazowsza competition for FluSensor SensDx – developing a solution for detecting the influenza virus at an early stage of infection!
We are pleased to announce that from today it will be possible to use Flu SensDx at home!
SensDx received the Good Design 2020 New Technologies award for Flu SensDx – a mobile diagnostic platform for pathogen detection!
Our vision is to revolutionize medical diagnosis worldwide by providing effective, rapid and easy-to-use tests to detect pathogens causing specific diseases.
Our mission is to prevent the spreading of bacteria and viruses by detecting pathogens at an early stage of development.
The innovative solution combines a simple tool based on a fast, ultra-sensitive diagnostic test with a mobile application for easy result interpretation.
The test tools are placed inside specially-designed devices called Mobi (for individual patients) or Pro (for medical professionals)
SensDX comprises of an interdisciplinary team of experts specialising in biotechnological, chemical, electrochemical and electronic sciences, IT, production automation and business, including IP protection, technology commercialisation, sales and marketing. We work in line with modern management methods, high quality standards and safety regulations.
The dynamic growth of SensDx has been facilitated by funds obtained through a wide range of subsidies. While evaluating the SensDx applications, experts appreciated not only the technology, which will have a wide range of applications in telemedicine and diagnostics, but also the innovative functionality, huge commercialisation potential and business model, implemented consistently by SensDx.Learn more
District Court for the Capital City of Warsaw in Warsaw
XIII Commercial Department of the National Court Register
Share capital: 100 000 zł (paid in full)
ul. Postępu 14B, 02-676 Warszawa
ul. Kampinoska 25, 80-180 Gdańsk
ul. Bierutowska 57-59, 51-317 Wrocław
(Wrocławski Park Biznesu 3)
ul. Nałęczowska 14, 20-701 Lublin
ul. Kampinoska 25, 80-180 Gdańsk
Click here for more information about international distribution
Poland, Czech Republic, Slovakia, Hungary
Foreign currency accounts:
PLN: PL 72 1240 6410 1111 0010 6100 8930
EUR: PL 04 1240 1112 1978 0010 9610 3439
USD: PL 94 1240 1112 1787 0011 0139 2049